It also aimed to determine the percentage of patients achieving various IHC scores correlating with the ISH results and to establish a database for GC patients in Lebanon in terms of referral and treatment trends of GC, taking into consideration several prognostic factors, mainly HER2-neu status and disease stage. This evidence concerns the gene ERBB2 and gastric cancer.